Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt) has been approved by the US Food and Drug Administration (FDA) to treat ...

Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

Xaira Therapeutics, a new biotech aiming to “re-engineer” drug discovery and development using artificial intelligence (AI), ...

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients ...

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) in combination with its endocrine therapy Faslodex (fulvestrant) has ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

The use of systemic radioactive medications as cancer therapies dates back to the 1940s when radioactive iodine was employed ...

Up to 40% of patients who have undergone definitive prostate cancer treatment will experience biochemical recurrence within ...

AstraZeneca’s (AZ) Voydeya (danicopan) has been approved by the European Commission (EC) as an add-on therapy for adults with ...